Short answer
Core Laboratories Inc. /DE/ (CLB) filed its Q2 2026 10-Q quarterly report on Jul 30, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $125M (down 4.3% year over year) with net income of $6M.
Q2 2026 key financials · XBRL
- Revenue
- $125M
- −4.3% YoY · +2.3% QoQ
- Net income
- $6M
- −44.0% YoY · +854.9% QoQ
- Operating margin
- 7.3%
- EPS (diluted)
- $0.13
- −40.9% YoY · +750.0% QoQ
Source: XBRL data from the Core Laboratories Inc. /DE/ (CLB) Q2 2026 10-Q on SEC EDGAR. USD.
Core Laboratories Inc. /DE/ Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Risk Factors
- No risk-factors section provided in submitted filing text
- No new or changed regulatory, legal, operational, competitive, market, or financial risks identifiable
- Open-market repurchases: 213,928 shares repurchased during quarter
- Share repurchases discretionary, with no publicly announced program
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other Core Laboratories Inc. /DE/ quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.